|
Vorobyeva N.M., Malaya I.P., Zakiev V.D., Tkacheva O.N.
How to increase the safety of antithrombotic therapy in cardiology patients
|
№2 / 2024
|
|
Vorobyeva N.M., Malaya I.P., Alimova E.R., Tkacheva O.N.
Prevention of gastrointestinal bleeding in patients with atrial fibrillation receiving oral anticoagulants: Whom? When? How?
|
№5 / 2023
|
|
Ostroumova O.D., Orlova I.Yu., Kochetkov A.I., Polyakova O.A., Listratov A.I., Shatalova N.A., Batyukina S.V.
Structure of polymorbidities of the digestive diseases in patients receiving direct oral anticoagulants: results of a multicenter cross-sectional pharmacoepidemiological study
|
№10 / 2022
|
|
Dronova Y.M., Belesikova V.V.
The validity of prescribing drug prevention of gastroduodenal bleeding in patients with chronic ischemic heart disease
|
№4 (приложение) / 2022
|
|
Vorobyeva N.M., Tkacheva O.N.
Safety of antithrombotic therapy in cardiological practice: how to protect tunica mucosa of gastrointestinal tract?
|
№4 / 2022
|
|
Borovkova N.Yu., Buyanova M.V., Bakka T.E., Nistratova M.P.
Pathogenetic approaches to treatment of aspirin-induced gastroenteropathies in case of long-term intake of acetylsalicylic acid in patients with chronic ischemic heart disease
|
№3 / 2020
|
|
Kucheryavy Yu.A., Andreev D.N., Shaburov R.I.
Proton pump inhibitors in the practice of physician
|
№5 / 2019
|
|
Dydykina I.S., Kovalenko P.S.
Main aspects of prevention and treatment of NSAIDS-gastropathy in the light of new ideology of the modern medicine
|
№1 / 2019
|
|
O.M. Mikheeva
Proton-pump inhibitors for treatment of acid diseases
|
№2 / 2016
|
|
Ye.Yu. Eremina
Management of patient with gastroesophageal reflux disease
|
№2 / 2016
|
|
G.L. Yurenev, A.N. Kazyulin, T.V. Yureneva-Tkhorzhevskaya
The influence of acid-suppressive therapy on the clinical course of ischemic heart disease with refractory pain syndrome in the chest
|
№2 / 2015
|
Русский
